Globus Medical Inc - Ordinary Shares - Class A
GMED
Market Cap$7.2B
Close$
$76.67
19% upside
Current Fair Value
19% upsideUndervalued by 19% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.20 Billion |
|---|---|
| Enterprise Value | $7.19 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.54 |
| Beta | 1.03 |
| Outstanding Shares | 112,624,816 |
| Avg 30 Day Volume | 1,330,149 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 108.1 |
|---|---|
| PEG | -94.42 |
| Price to Sales | 4.03 |
| Price to Book Ratio | 1.89 |
| Enterprise Value to Revenue | 3.79 |
| Enterprise Value to EBIT | 41.43 |
| Enterprise Value to Net Income | 107 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
ESG Score
No data
About Globus Medical Inc
CEO: David Demski